Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 26.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment o |
| 10.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 3(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment |
| 12.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; C |
| 27.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compens |
Stammdaten
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Unternehmen & Branche
| Name | PFIZER INC |
|---|---|
| Ticker | PFE |
| CIK | 0000078003 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - General |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 002824253 |
|---|---|
| ISIN | US0028242537 |
| Typ | Common Stock |
| Marktkapitalisierung | 150,43 Mrd. USD |
| Beta | 0,39 |
| Dividendenrendite | 1,72 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 62,579,000,000 | 7,771,000,000 | 1.36 | 208,160,000,000 | 86,476,000,000 |
| 2025-09-28 | 10-Q | 16,654,000,000 | 3,541,000,000 | 0.62 | 208,731,000,000 | 92,801,000,000 |
| 2025-06-29 | 10-Q | 14,653,000,000 | 2,910,000,000 | 0.51 | 206,095,000,000 | 88,695,000,000 |
| 2025-03-30 | 10-Q | 13,715,000,000 | 2,967,000,000 | 0.52 | 208,028,000,000 | 90,338,000,000 |
| 2024-12-31 | 10-K | 63,627,000,000 | 8,031,000,000 | 1.41 | 213,396,000,000 | 88,203,000,000 |
| 2024-09-29 | 10-Q | 17,702,000,000 | 4,465,000,000 | 0.78 | 219,476,000,000 | 92,286,000,000 |
| 2024-06-30 | 10-Q | 13,283,000,000 | 41,000,000 | 0.01 | 216,193,000,000 | 87,700,000,000 |
| 2024-03-31 | 10-Q | 14,879,000,000 | 3,115,000,000 | 0.55 | 221,095,000,000 | 92,282,000,000 |
| 2023-12-31 | 10-K | 59,553,000,000 | 2,119,000,000 | 0.37 | 226,501,000,000 | 89,014,000,000 |
| 2023-10-01 | 10-Q | 13,491,000,000 | -2,382,000,000 | -0.42 | 215,021,000,000 | 96,934,000,000 |
| 2023-07-02 | 10-Q | 13,007,000,000 | 2,327,000,000 | 0.41 | 220,168,000,000 | 99,019,000,000 |
| 2023-04-02 | 10-Q | 18,486,000,000 | 5,543,000,000 | 0.97 | 195,617,000,000 | 100,970,000,000 |
| 2022-12-31 | 10-K | 101,175,000,000 | 31,372,000,000 | 5.47 | 197,205,000,000 | 95,661,000,000 |
| 2022-10-02 | 10-Q | 22,638,000,000 | 8,608,000,000 | 1.51 | 195,350,000,000 | 92,631,000,000 |
| 2022-07-03 | 10-Q | 27,742,000,000 | 9,906,000,000 | 1.73 | 195,290,000,000 | 87,208,000,000 |
| 2022-04-03 | 10-Q | 25,661,000,000 | 7,864,000,000 | 1.37 | 183,841,000,000 | 82,424,000,000 |
| 2021-12-31 | 10-K | 81,288,000,000 | 21,979,000,000 | 3.85 | 181,476,000,000 | 77,201,000,000 |
| 2021-10-03 | 10-Q | 24,035,000,000 | 8,146,000,000 | 1.42 | 179,188,000,000 | 75,691,000,000 |
| 2021-07-04 | 10-Q | 18,899,000,000 | 5,563,000,000 | 0.98 | 169,920,000,000 | 70,042,000,000 |
| 2021-04-04 | 10-Q | 14,516,000,000 | 4,877,000,000 | 0.86 | 158,818,000,000 | 68,620,000,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 541,346,182 | 0 | 541,346,182 | 13,479,519,929 | Neu | +100,0% | |
| BlackRock, Inc. | 493,062,528 | 0 | 493,062,528 | 12,277,256,927 | Neu | +100,0% | |
| STATE STREET CORP | 300,445,164 | 0 | 300,445,164 | 7,481,084,584 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 130,192,081 | 0 | 130,192,081 | 3,235,641,726 | Neu | +100,0% | |
| MORGAN STANLEY | 89,113,604 | 0 | 89,113,604 | 2,218,928,830 | Neu | +100,0% | |
| NORGES BANK | 73,533,577 | 0 | 73,533,577 | 1,830,986,067 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 63,250,589 | 0 | 63,250,589 | 1,574,939,666 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 62,961,082 | 0 | 62,961,082 | 1,567,730,942 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 55,873,002 | 0 | 55,873,002 | 1,391,237,751 | Neu | +100,0% | |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 54,508,560 | 0 | 54,508,560 | 1,357,263,144 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 52,094,310 | 0 | 52,094,310 | 1,297,148,319 | Neu | +100,0% | |
| Fisher Asset Management, LLC | 51,952,106 | 0 | 51,952,106 | 1,293,607,468 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 50,540,119 | 0 | 50,540,119 | 1,258,449,100 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 48,781,192 | 0 | 48,781,192 | 1,214,651,665 | Neu | +100,0% | |
| Legal & General Group Plc | 42,864,225 | 0 | 42,864,225 | 1,067,319,208 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 41,535,562 | 0 | 41,535,562 | 1,034,235,487 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 36,580,269 | 0 | 36,580,269 | 910,850,000 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 36,129,770 | 0 | 36,129,770 | 899,664,533 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 35,713,035 | 0 | 35,713,035 | 889,254,570 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 34,350,976 | 0 | 34,350,976 | 855,339,303 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 30,898,848 | 0 | 30,898,848 | 769,381,314 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 29,336,821 | 0 | 29,336,821 | 730,486,843 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 27,658,547 | 0 | 27,658,547 | 688,697,862 | Neu | +100,0% | |
| Invesco Ltd. | 27,260,059 | 0 | 27,260,059 | 678,775,467 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 16,635,120 | 0 | 16,635,120 | 676,644,104 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 25,164,327 | 0 | 25,164,327 | 626,591,751 | Neu | +100,0% | |
| BARCLAYS PLC | 24,094,489 | 0 | 24,094,489 | 599,952,779 | Neu | +100,0% | |
| Capital World Investors | 21,433,890 | 0 | 21,433,890 | 533,703,887 | Neu | +100,0% | |
| VICTORY CAPITAL MANAGEMENT INC | 19,796,365 | 0 | 19,796,365 | 492,929,488 | Neu | +100,0% | |
| UBS Group AG | 18,988,620 | 0 | 18,988,620 | 472,816,625 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 18,768,836 | 0 | 18,768,836 | 467,344,023 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 18,391,105 | 0 | 18,391,105 | 458,132,484 | Neu | +100,0% | |
| CITIGROUP INC | 17,039,419 | 0 | 17,039,419 | 424,281,548 | Neu | +100,0% | |
| HSBC HOLDINGS PLC | 15,934,233 | 0 | 15,934,233 | 397,018,405 | Neu | +100,0% | |
| Swiss National Bank | 15,580,012 | 0 | 15,580,012 | 387,942,299 | Neu | +100,0% | |
| SOUTH PLAINS FINANCIAL, INC. | 14,799 | 0 | 14,799 | 368,343,000 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 14,461,914 | 0 | 14,461,914 | 360,101,659 | Neu | +100,0% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 13,973,991 | 0 | 13,973,991 | 347,952,376 | Neu | +100,0% | |
| SUSQUEHANNA ADVISORS GROUP, INC. | 13,600,000 | 0 | 13,600,000 | 338,640,000 | Neu | +100,0% | |
| National Pension Service | 13,439,182 | 0 | 13,439,182 | 334,635,632 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 13,372,593 | 0 | 13,372,593 | 332,977,565 | Neu | +100,0% | |
| LPL Financial LLC | 13,299,980 | 0 | 13,299,980 | 331,169,479 | Neu | +100,0% | |
| Squarepoint Ops LLC | 12,376,966 | 0 | 12,376,966 | 308,186,453 | Neu | +100,0% | |
| FMR LLC | 12,275,140 | 0 | 12,275,140 | 305,650,966 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 11,500,713 | 0 | 11,500,713 | 286,543,512 | Neu | +100,0% | |
| Robeco Institutional Asset Management B.V. | 9,870,643 | 0 | 9,870,643 | 245,779,014 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 9,819,833 | 0 | 9,819,833 | 244,513,854 | Neu | +100,0% | |
| BANK OF MONTREAL /CAN/ | 9,676,579 | 0 | 9,676,579 | 240,946,834 | Neu | +100,0% | |
| DIAMOND HILL CAPITAL MANAGEMENT INC | 9,439,267 | 0 | 9,439,267 | 235,037,748 | Neu | +100,0% | |
| STIFEL FINANCIAL CORP | 9,277,361 | 0 | 9,277,361 | 231,007,604 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| OPPENHEIMER & CO INC | 831,613 | 23,351,693 | 90.67 |
| GAGNON SECURITIES LLC | 44,260 | 1,242,821 | 4.83 |
| PW Nova Financial Services LLC | 19,627 | 551,109 | 2.14 |
| MANCHESTER FINANCIAL INC | 12,803 | 359,509 | 1.40 |
| ECLECTIC ASSOCIATES INC /ADV | 8,844 | 248,350 | 0.96 |